PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Symptom | C0011849|diabetes mellitus |
| Sentences | 68 |
| PubMedID- 23387219 | The correlation of serum cystatin c level with the severity of carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 23678326 | Chronic subclinical inflammation is considered to be important for the initiation and / or progression of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 24797048 | Plasma apob level was not independently associated with ultrasonographic phenotypes of carotid atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 22553973 | Hyperglycemia is considered one of the major pathogenic factors for atherogenesis and the progression of atherosclerosis in diabetes mellitus . |
| PubMedID- 25253014 | Evaluation of left ventricular myocardial function in coronary atherosclerosis patients with type 2 diabetes mellitus by speckle tracking echocardiography. |
| PubMedID- 24318519 | This study aimed to assess relationship between mvp and the severity of coronary atherosclerosis in patients with diabetes mellitus (dm), stable cad and normal left ventricular ejection fractions. |
| PubMedID- 21996253 | Aims: to analyze the relationship between serum levels of osteocalcin and parameters of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 19853860 | Objective: to compare aortic intima media thickness (aimt) to carotid intima media thickness (cimt) as a marker of early atherosclerosis in children with type 1 diabetes mellitus and to examine the associations of aimt to known cardiovascular risk factors. |
| PubMedID- 22330623 | The gstt1-0 genotype and gstt1-0/gstm1-0 haplotype might be a potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 25456820 | High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 25851542 | suggested that ga was a more valuable index than hba1c for predicting the progression of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 25509887 | Aim: to study the prognostic value of multifocal atherosclerosis (mfa) in patients with diabetes mellitus (dm) at high risk for myocardial ischemia who need coronary angiography (cag). |
| PubMedID- 25708055 | In conclusion, cumulative active and passive smoking exposures are significant risk factors for carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 23574730 | Postprandial hyperglycemia and/or hyperlipidemia can contribute to development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 22022185 | It has been shown that atherosclerosis in patients with diabetes mellitus (dm) can lead to acute coronary artery disease, ischemic cerebral disease, and peripheral arterial disease (2). |
| PubMedID- 24392103 | While pwv is affected by changes in instantaneous blood pressure, the cardio-ankle vascular index (cavi) is a blood pressure-independent index of systemic arterial stiffness, and is often used as a marker of early arteriosclerosis associated with hypertension, diabetes mellitus, dyslipidemia and smoking 5. |
| PubMedID- 20108050 | Since postprandial lipoproteins are atherogenic, the delay in clearance of these particles could play an important role in the development of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 26161507 | Chronic kidney disease (ckd) is associated with atherosclerosis in patients with diabetes mellitus (dm) and in nondiabetic individuals 1. |
| PubMedID- 26251624 | The development of atherosclerosis in patients with type 2 diabetes mellitus (t2dm) may be due to hypercoagulability and platelet hyperaggregability,1,2 along with increased levels of platelet activation markers. |
| PubMedID- 26345606 | Therefore, serms may also be effective in reducing the progression of arteriosclerosis in patients with diabetes mellitus. |
| PubMedID- 25975128 | A relationship between cardiac structural and functional parameters, left ventricular contractility, and coronary atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22120969 | Glp-1 may prevent or delay the formation of atherosclerosis in diabetes mellitus by improving the function of enos. |
| PubMedID- 24768387 | Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: prologue study. |
| PubMedID- 26505665 | Method: this case-control study included 596 type 2 diabetes mellitus patients with carotid atherosclerosis and 379 patients without carotid atherosclerosis. |
| PubMedID- 21227528 | Association of serum trail levels with atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 24739810 | Increased levels of adma were found in the development of carotid atherosclerosis in patients with type 2 diabetes mellitus (t2dm) , in subjects with early asymptomatic carotid atherosclerosis , and especially in patients with chronic kidney disease (ckds) and rheumatoid arthritis . |
| PubMedID- 26069232 | Little data exist about the relationship of apoc-iii, triglycerides, and atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25120969 | Effect of age and blood pressure on surrogate markers of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 25953645 | Conclusions: the plasma level of mmp-7 and -12 are elevated in type 2 diabetes mellitus, associated with more severe atherosclerosis and an increased incidence of coronary events. |
| PubMedID- 26041310 | Cardiac ct in asymptomatic diabetes mellitus: role of non-invasive atherosclerosis imaging in high-risk asymptomatic individuals. |
| PubMedID- 21957962 | This may contribute to atherosclerosis in diabetes mellitus. |
| PubMedID- 21483695 | Part of the increased susceptibility to atherosclerosis of patients with type 2 diabetes mellitus and the metabolic syndrome has been attributed to the decreased clearance of trps , . |
| PubMedID- 20516379 | The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (dapc) study: a randomized trial. |
| PubMedID- 24593955 | Altered lipids and lipoprotein metabolism in chronic diabetes mellitus is associated with pathogenesis of atherosclerosis and other cardiovascular diseases 5. |
| PubMedID- 23904855 | In this study, the total number for atherosclerosis in patients with type 2 diabetes mellitus increased with the progression of renal dysfunction. |
| PubMedID- 23347332 | Conclusions: diabetes mellitus may be associated with subclinical atherosclerosis assessed by measurement of avp and cimt. |
| PubMedID- 25992325 | Cardiovascular (cv) complications are an essential causal element of prospect in diabetes mellitus (dm), with carotid atherosclerosis being a common risk factor for prospective crisis of coronary artery diseases and/or cerebral infarction in dm subjects. |
| PubMedID- 20004424 | We investigated the relationship between hemoglobin concentration and various factors as well as markers of subclinical atherosclerosis in men with type 2 diabetes mellitus. |
| PubMedID- 23761984 | The cross-linking activity is aimed at stabilizing the interaction of microtubules with the plasma membrane, demonstrating that transglutaminase activity can affect protein secretion and matrix deposition in osteoblasts.54,55 fxiii has been shown to have a direct role on vascular endothelial cells in promoting angiogenesis in vitro and in vivo on animal models.56 insulin resistance and diabetes mellitus is associated with prothrombotic states, atherosclerosis, dyslipidemia, and obesity. |
| PubMedID- 21747057 | Background: endothelial dysfunction contributes to the development of atherosclerosis in patients with diabetes mellitus, but the mechanisms of endothelial dysfunction in this setting are incompletely understood. |
| PubMedID- 24678948 | Contribution of subcutaneous abdominal fat on ultrasonography to carotid atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 23724401 | Vitamin d deficiency has been to be associated with cvd risk factors such as hypertension and diabetes mellitus, with markers of subclinical atherosclerosis such as intima-media thickness and coronary calcification as well as with cardiovascular events such as myocardial infarction, stroke and congestive heart failure. |
| PubMedID- 25537059 | Background: we aimed to investigate the association of toenail onychomycosis with subclinical atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 21779189 | Leptin and adiponectin can be more relevant to atherosclerosis in subjects with obesity and diabetes mellitus than conventional atherosclerotic factors such as bp and lipid levels . |
| PubMedID- 24423050 | The gstt1-null genotype and combined gstt1*0/gstm1*0 might be potential determinants of susceptibility to advanced atherosclerosis in patients with type 2 diabetes mellitus . |
| PubMedID- 25875738 | However, little is known about the association between glycemic control and objective sleep architecture and its influence on arteriosclerosis in patients with type-2 diabetes mellitus (dm). |
| PubMedID- 22421230 | Objectives: the goal of this study was to characterize the extent and composition of coronary atherosclerosis in patients with diabetes mellitus or the metabolic syndrome (met syn) presenting with acute coronary syndromes (acs). |
| PubMedID- 22368195 | Aims: several studies have demonstrated that type 2 diabetes mellitus (t2dm) is associated with accelerated atherosclerosis, which results in an increased risk of coronary vascular events. |
| PubMedID- 20194881 | Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial. |
| PubMedID- 23936869 | Other signs include type 2 diabetes mellitus, osteoporosis, evidence of premature atherosclerosis, malignances, voice changes, and flat feet. |
Page: 1 2